NCT07890194|RecruitingDMC
Loading search results
Sponsor study identifier
interventional
30
1 country
1
Study Start
August 31, 2026
Actual (reported)Primary Completion
December 20, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 20, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
This study will evaluate whether adding individualized pelvic floor muscle rehabilitation to standard urotherapy and alarm treatment improves bedwetting in children aged 5-18 years with primary monosymptomatic nocturnal enuresis. Participants will be randomly assigned to two groups. Both groups will receive standard urotherapy and alarm treatment. One group will also receive pelvic floor muscle rehabilitation for 12 weeks. The study will compare dry nights, alarm activations, and changes in pelvic floor muscle function between the groups.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 20, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 31, 2026
Actual (reported)October 16, 2026
Actual (reported)October 22, 2026
Actual (reported)December 20, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
December 20, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Number of Dry Nights
The number of nights without involuntary urine leakage during sleep will be recorded by parents using an enuresis diary.
Baseline and weeks 4, 8, and 12.
Number of Enuresis Alarm Activations
The number of moisture-triggered enuresis alarm activations during sleep will be recorded by parents using an enuresis diary.
Baseline and weeks 4, 8, and 12.
Treatment Response According to ICCS Criteria
Baseline and weeks 12.
Dysfunctional Voiding and Incontinence Scoring System (DVISS) Score
Baseline and weeks 4, 8, and 12.
Nocturnal Enuresis Symptom Score (NESS)
Baseline and weeks 4, 8, and 12.
Participants will receive standard urotherapy, alarm therapy, and pelvic floor muscle rehabilitation for 12 weeks.
Participants will receive standard urotherapy and alarm therapy for 12 weeks.
Participants will receive standard urotherapy and alarm therapy for 12 weeks.
Participants will receive standard urotherapy, alarm therapy, and pelvic floor muscle rehabilitation for 12 weeks.
Hacettepe University
Ankara, Ankara, 06680, Turkey (Türkiye)
Türkan AKBAYRAK, Prof. Dr.
Hacettepe University
Canan Seyhan, Ph.D. (c)
Hacettepe University
Murat DAYANÇ, Prof. Dr.
Private Dayanc Pediatric Urology Center
First Submitted
October 16, 2026
First Posted
October 22, 2026
Study Start
August 31, 2026
Actual (reported)Primary Completion
December 20, 2028
EstimatedRegistry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 20, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
October 22, 2026
Record last verified: 2026-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: